The essentials for stress-free management of patients with polycystic kidney disease on peritoneal dialysis.
Summary Autosomal dominant polycystic hepatorenal disease is a common chronic kidney disease. Among the proposed replacement therapies, peritoneal dialysis (PD) concerns less than 7% of polycystic patients. The underutilization of PD is due to the fear of potential technical failure due to its poten...
Saved in:
Main Author: | Fatouma Toure (Author) |
---|---|
Format: | Book |
Published: |
RDPLF,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peritoneal dialysis in polycystic kidney disease patients
by: Hajar Benzouina, et al.
Published: (2020) -
Evolution of peritoneal dialysis technique failure from 2002 to 2017 in France. RDPLF data.
by: Benoît SCHWARTZ, et al.
Published: (2018) -
Is Peritoneal Dialysis a Suitable Renal Replacement Therapy Option for Polycystic Kidney Disease Patients?
by: Tao Zhang, et al.
Published: (2018) -
Patients' outcome with polycystic kidney disease firstly treated with peritoneal dialysis. Experience of our home dialysis unit since 1997.
by: jean-michel Poux, et al.
Published: (2021) -
Case report about three patients affected by autosomal dominant polycystic kidney disease who started peritoneal dialysis after nephrectomy and simultaneous peritoneal catheter implantation.
by: Lise Lelandais, et al.
Published: (2019)